Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders.
The term pediatric autoimmune enteropathy was originally applied to a form of intractable diarrhea seen in children under the age of 6 months and characterized by male predominance, concurrent autoimmune-associated disorders, circulating gut autoantibodies, a lack of severe immunodeficiency and small bowel atrophy with prominent crypt apoptosis. However, recent studies have cast doubt over the specific clinicopathologic findings associated with this entity. We, therefore, collected 178 gastrointestinal biopsies from 14 patients and examined their clinical, serologic and pathologic findings. Patients at presentation ranged in age from birth to 15.9 years (median, 5.5 months; mean, 4.1 years) and included six males and eight females. All children suffered from chronic watery diarrhea and malnutrition. Concomitant-associated disorders were noted in 11 (79%) cases and included 10 (71%) with an immunodeficiency disorder and/or another autoimmune-related disease. Eleven patients (79%) were positive for anti-enterocyte antibodies. The salient findings of autoimmune enteropathy were most prominent in the small intestines and the majority (79%) of patients demonstrated villous blunting, crypt hyperplasia, mononuclear cell inflammatory expansion of the lamina propria and crypt apoptosis. The remaining (21%) patients showed marked intraepithelial lymphocytosis reminiscent of celiac disease. Further, acute cryptitis and crypt abscesses were seen in seven (50%) patients obscuring the presence of apoptosis. The absence of Paneth cells, goblet cells or both was noted in seven (50%) patients. Follow-up information was available for all patients with 13 (93%) receiving immunosuppressant therapy and demonstrating partial-to-complete response. In total, three patients died from continued diarrhea and sepsis with one decedent before treatment could be initiated. In summary, autoimmune enteropathy in children is a heterogenous disease with protean clinical and pathologic findings. Although anti-enterocyte antibodies were identified in the majority of the cases, their presence was variable and insensitive. In addition, pediatric autoimmune enteropathy was frequently encountered in the setting of immunodeficiency disorders.
Department of Pathology, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Aatur D
AD
Singhi
Department of Pediatrics, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Alka
A
Goyal
Department of Pathology, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Jon M
JM
Davison
Department of Medicine, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Miguel D
MD
Regueiro
Department of Pathology, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Robyn L
RL
Roche
Department of Pathology, The University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Sarangarajan
S
Ranganathan
D000293:Adolescent; D001323:Autoantibodies / Q000032:analysis*; D015551:Autoimmunity / Q000187:drug effects; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D003967:Diarrhea / Q000276:immunology; D020895:Enterocytes / Q000276:immunology / Q000473:pathology; D005260:Female; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016884:Polyendocrinopathies, Autoimmune / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D011237:Predictive Value of Tests; D018805:Sepsis / Q000276:immunology; D016896:Treatment Outcome
D001323:Autoantibodies; D007166:Immunosuppressive Agents